Colgate-Palmolive stock edges lower as Barclays conference highlights growth plan and valuation
Published on 09/09/2026 at 20:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Colgate-Palmolive stock (ISIN US1941621039) closed at USD 88.37 on the New York Stock Exchange on September 8, 2026, roughly 11 percent below its 52-week high of USD 99.33 and corresponding to a market capitalization of about USD 70.5 billion.
Barclays conference puts growth strategy in focus
On September 9, 2026, Colgate-Palmolive used Barclays 19th Annual Global Consumer Conference to outline the next phase of its growth strategy, emphasizing a shift from chasing growth to scaling capabilities built over the past five years.Investing.com reported that Chief Executive Noel Wallace continues to target an organic sales growth algorithm of 3% to 5%, with the back half of 2026 expected to lean more on volume growth than pricing.
According to Investing.com, Colgate-Palmolive described the first half of 2026 as a solid period, with emerging markets and its Hill's Pet Nutrition business offsetting a difficult environment in North America. Wallace highlighted that private-label products should exit the portfolio almost completely by the end of the third quarter and be fully cleared by the fourth quarter of 2026, a move intended to make volume trends easier to read and support more sustainable organic growth.
Recent fundamentals and margin performance
Colgate-Palmolive’s most recent reported quarter showed moderate top-line growth coupled with margin expansion. In its second-quarter 2026 results, the company delivered organic sales growth of about 2.4 percent, within a full-year guidance range of 1 percent to 4 percent, reflecting balanced pricing and volume contributions across its categories.Tikr noted that Colgate-Palmolive’s gross margin expanded by 140 basis points in the quarter to 61.5 percent, significantly above a roughly 51 percent gross margin level cited for a key peer, highlighting the profitability of Colgate’s oral and personal care focus.
At the Barclays conference, Noel Wallace reiterated that Colgate-Palmolive still aims to deliver its 3 percent to 5 percent organic growth algorithm, and he indicated that pricing should moderate in the second half of 2026 while volume growth accelerates.Investing.com reported that, excluding private-label products, second-quarter 2026 volume growth reached about 1.2 percent, and the company expects volume to take a larger role in its growth profile as pricing contributions fade.
For comparison, a recent analysis highlighted that Colgate-Palmolive’s gross margin at 61.5 percent in the latest quarter stands well above a roughly 51 percent trailing margin at Procter & Gamble, underlining Colgate’s ability to generate high profitability in its core categories.Tikr This margin spread is a key quantitative differentiator for investors comparing household and personal care peers.
Valuation, market metrics and analyst view
The Barclays discussion also underscored that Colgate-Palmolive shares trade at a relatively rich multiple, yet some screens still flag the stock as modestly undervalued. As of September 9, 2026, Investing.com cited a market capitalization of USD 70.5 billion and a price-to-earnings ratio around 35 for Colgate-Palmolive, while an InvestingPro fair-value analysis placed the shares on an undervalued opportunities list.
Separate valuation work pointed to a trailing price-to-earnings ratio of about 35.08 times for Colgate-Palmolive, slightly above its five-year median P/E of 31.26 times, but still consistent with the company’s long-term premium relative to the broader market.GuruFocus In that analysis, an intrinsic value estimate around USD 95.24 was compared with a contemporaneous share price of USD 88.41, implying roughly 7.2 percent upside and framing Colgate-Palmolive as modestly undervalued relative to its GF Value metric.
On the sell-side, Colgate-Palmolive currently carries an average analyst rating characterized as Moderate Buy, with a consensus price target of USD 99.00, indicating potential upside from the recent closing price.MarketBeat For investors, this means the consensus target sits about 12 percent above the USD 88.37 closing level from September 8, 2026, a gap that quantifies the degree to which analysts expect fundamentals and execution to translate into share-price appreciation.
North America reset and emerging-market strength
Operationally, management continues to address a clear regional divergence between North America and faster-growing emerging markets. At the Barclays conference on September 9, 2026, Noel Wallace described North America as the company’s most challenging geography, with inventory adjustments, competitive pressure and underperformance in premium oral care weighing on results.Investing.com Wallace said a strategic reset under new leadership in North America includes stepped-up premium innovation, more sophisticated revenue growth management and targeted couponing, all aimed at restoring organic growth and market share.
In contrast, Colgate-Palmolive’s emerging-market operations continue to provide the main engine for growth. Management highlighted strong second-quarter 2026 performance in Latin America, with mid-to-high single-digit growth in key countries such as Brazil and Mexico, supported by balanced price and volume contributions and a broad innovation pipeline.Investing.com Wallace underscored that six countries — Mexico, Brazil, India, China, Nigeria and Bangladesh — are expected to account for about 65 percent of global middle-class expansion and 25 percent of global population growth over the next five years, reinforcing Colgate-Palmolive’s focus on emerging markets as the long-term growth anchor.
For investors, the quantified picture is clear: the company is leveraging high-margin categories and broad geographic diversification, with gross margin in the latest quarter at 61.5 percent and organic sales growth of 2.4 percent, while simultaneously targeting 3 percent to 5 percent annual organic growth despite subdued category growth in developed markets.Tikr The main risk factor, also highlighted at Barclays, remains the need to execute a multi-year turnaround in North America without sacrificing profitability, while managing selective pricing and promotional moves in a competitive environment.
Stock level and investor takeaway
On the price side, Colgate-Palmolive stock last traded at USD 88.37 on the New York Stock Exchange on September 8, 2026, with a 52-week range between USD 74.54 and USD 99.33 and a market capitalization around USD 70.5 billion at that level.MarketBeat With the shares trading roughly 11 percent below the 52-week high and analysts’ consensus target at USD 99.00, the valuation leaves room for potential upside if the company can sustain mid-single-digit organic growth and continue expanding margins, particularly in its high-margin oral care and pet nutrition businesses.
Key data on Colgate-Palmolive stock
- Company: Colgate-Palmolive Company
- ISIN: US1941621039
- Ticker: CL
- Trading venue: NYSE
- Price (as of September 8, 2026): 88.37 USD
- Market capitalization: 70.5 billion USD (as of September 9, 2026)
- Sector / Industry: Consumer staples / Household and personal care
- Index membership: S&P 500
